Previous studies in patients with non-small cell lung cancer have shown that proteins commonly used to screen tumor biomarkers can be used as exosome biomarkers of non-small cell lung cancer, such as EGFR, CD151, CD171, tetraspanin 8 [40], and NY-ESO-1 [41]. This evidence concerns the gene CD151 and neoplasm.